We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$954M
AUM Growth
+$9.5M
Cap. Flow
-$5.76M
Cap. Flow %
-0.6%
Top 10 Hldgs %
31.59%
Holding
125
New
1
Increased
40
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$6.35M
2
ROK icon
Rockwell Automation
ROK
+$5.65M
3
MDLZ icon
Mondelez International
MDLZ
+$1.91M
4
ZTS icon
Zoetis
ZTS
+$1.2M
5
MCD icon
McDonald's
MCD
+$1.19M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.52M
2
GLW icon
Corning
GLW
+$3.61M
3
NVDA icon
NVIDIA
NVDA
+$2.6M
4
AAPL icon
Apple
AAPL
+$2.31M
5
BUD icon
AB InBev
BUD
+$1.62M

Sector Composition

Rank Sector Weight
1 Technology 30.15%
2 Healthcare 16.16%
3 Industrials 14.45%
4 Consumer Staples 11.39%
5 Consumer Discretionary 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPM icon
101
RPM International
RPM
$13.7B
$429K 0.05%
3,990
– –
COP icon
102
ConocoPhillips
COP
$147B
$391K 0.04%
3,421
– –
T icon
103
AT&T
T
$159B
$379K 0.04%
19,866
-25,408
-56% -$442K
SCHB icon
104
Schwab US Broad Market ETF
SCHB
$43.2B
$355K 0.04%
16,944
+195
+1% +$3.95K
GAM
105
General American Investors Company
GAM
$1.56B
$353K 0.04%
7,116
-400
-5% -$18.9K
PSX icon
106
Phillips 66
PSX
$84.9B
$334K 0.04%
2,366
– –
SNY icon
107
Sanofi
SNY
$103B
$324K 0.03%
6,690
-225
-3% -$10.9K
TTD icon
108
Trade Desk
TTD
$8.48B
$317K 0.03%
3,250
+75
+2% +$6.77K
BAX icon
109
Baxter International
BAX
$13.5B
$309K 0.03%
9,254
-1,965
-18% -$72.4K
IWV icon
110
iShares Russell 3000 ETF
IWV
$19.6B
$303K 0.03%
982
– –
SLB icon
111
SLB Ltd
SLB
$73.6B
$297K 0.03%
6,300
-50
-0.8% -$2.41K
NVS icon
112
Novartis
NVS
$297B
$292K 0.03%
2,750
– –
HPQ icon
113
HP
HPQ
$24.9B
$260K 0.03%
7,425
– –
LMT icon
114
Lockheed Martin
LMT
$134B
$256K 0.03%
550
– –
MAS icon
115
Masco
MAS
$14.1B
$253K 0.03%
3,805
-240
-6% -$16.9K
QQQ icon
116
Invesco QQQ Trust
QQQ
$453B
$249K 0.03%
520
-16
-3% -$7.2K
TXN icon
117
Texas Instruments
TXN
$252B
$247K 0.03%
+1,273
New +$235K
AFL icon
118
Aflac
AFL
$64.9B
$230K 0.02%
2,577
+200
+8% +$17.2K
SCHF icon
119
Schwab International Equity ETF
SCHF
$66.6B
$210K 0.02%
10,950
– –
SHW icon
120
Sherwin-Williams
SHW
$82.7B
$210K 0.02%
705
– –
BAC icon
121
Bank of America
BAC
$435B
– –
-8,214
Closed -$311K
IJR icon
122
iShares Core S&P Small-Cap ETF
IJR
$109B
– –
-1,836
Closed -$202K
MDY icon
123
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
– –
-370
Closed -$205K
SYK icon
124
Stryker
SYK
$125B
– –
-1,900
Closed -$679K
UNH icon
125
UnitedHealth
UNH
$376B
– –
-459
Closed -$227K
1 2 3 4
5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Jacobs & Co held 125 positions worth $954M, up 1% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.8%. Jacobs & Co opened 1 new position and exited 5, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q2 2024 buy was Texas Instruments: 1,273 shares worth $247K.
  • Jacobs & Co added most to ServiceNow in Q2 2024, an estimated $6.35M increase.
  • Jacobs & Co's biggest Q2 2024 reduction was Bristol-Myers Squibb, cutting an estimated $4.52M.
  • Jacobs & Co fully exited Stryker in Q2 2024, selling an estimated $679K.
  • Jacobs & Co's ten largest holdings make up 32% of its $954M portfolio in Q2 2024.
  • Jacobs & Co opened 1 new position and closed 5 in Q2 2024.
  • Jacobs & Co's portfolio value rose 1% quarter-over-quarter to $954M.

Based on Jacobs & Co's 13F filing for Q2 2024, filed 12 Jul 2024.